diaziquone has been researched along with Cancer of Pancreas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bonnett, JD; Coltman, CA; Fleming, T; Harker, G; Mills, G; Natale, RB; Oishi, N; Tilchen, EJ | 1 |
| Bartolucci, AA; DeSimone, P; Kramer, B; Omura, GA | 1 |
3 other study(ies) available for diaziquone and Cancer of Pancreas
| Article | Year |
|---|---|
Phase II trials of the single agents baker's antifol, diaziquone, and epirubicin in advanced pancreatic cancer. Gastrointestinal Tumor Study Group.
Topics: Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Doxorubicin; Drug Evaluation; Epirubicin; Humans; Pancreatic Neoplasms; Triazines | 1987 |
Phase II evaluation of diaziquone in pancreatic carcinoma: a Southwest Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Aziridines; Azirines; Benzoquinones; Drug Evaluation; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms | 1987 |
Phase II evaluation of diaziquone in gastric and pancreatic cancers. A Southeastern Cancer Study Group Trial.
Topics: Aged; Aziridines; Azirines; Benzoquinones; Carcinoma; Drug Evaluation; Female; Humans; Male; Middle Aged; Pancreatic Neoplasms; Stomach Neoplasms | 1986 |